Spondyloarthritis & psoriatic arthritis
Barriers and facilitators to application of treat-to-target management in psoriatic arthritis and axial spondyloarthritis in practice: A systematic literature review
Authors' conclusion
Various barriers and facilitators were identified, acting on several levels. Data in axSpA were scarce, as was evidence on certain components of T2T.
Study context
- Population
- Studies on barriers or facilitators to application of treat-to-target (T2T) in axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) in daily practice (MEDLINE/Embase up to December 2023)28 studies
- Outcome
- Barriers and facilitators to application of T2T, classified by level (HCP, patient, organisation)
Methodological detailsqualitative synthesis
- Qualitative synthesis
Main finding
As reported in the abstract
- Studies focused on PsA
- 21/28
- Studies including patients
- 23/28
- Studies including HCP
- 4/28
- Studies including both
- 1/28
- Barriers identified
- over 25
- Facilitators identified
- 15
Original publication
Barriers and facilitators to application of treat-to-target management in psoriatic arthritis and axial spondyloarthritis in practice: A systematic literature review. Semin Arthritis Rheum. Published 7 September 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →